Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery of [1,2,4]Triazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, et al.
Journal of Medicinal Chemistry
|
November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors
Oleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Journal of Medicinal Chemistry
|
August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists
Yuan Cheng, Brian K Albrecht, James Brown, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities
Yuan Cheng, James Brown, Ted C Judd, et al.
Journal of Medicinal Chemistry
|
March 8, 2008
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation
Jean-Christophe Harmange, Matthew M Weiss, Julie Germain, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease
Jian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Journal of Medicinal Chemistry
|
August 4, 2006
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
September 15, 2006
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Cell
|
April 23, 2024
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B Chong, Siwen Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery of [1,2,4]Triazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, et al.
Journal of Medicinal Chemistry
|
November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors
Oleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Journal of Medicinal Chemistry
|
August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists
Yuan Cheng, Brian K Albrecht, James Brown, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities
Yuan Cheng, James Brown, Ted C Judd, et al.
Journal of Medicinal Chemistry
|
March 8, 2008
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation
Jean-Christophe Harmange, Matthew M Weiss, Julie Germain, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease
Jian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Journal of Medicinal Chemistry
|
August 4, 2006
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
September 15, 2006
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Cell
|
April 23, 2024
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B Chong, Siwen Zhang, et al.
Page
of 3